Meeting
2015 Gastrointestinal Cancers Symposium
FOLFIRINOX for the treatment of advanced pancreatic cancer: U.K. West Midlands experience.
Authors
Ankit Jain
University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
Ankit Jain , Martin Scott-Brown , Peter Denzil Correa , Sharmila Sothi , Amy Davies , Charles Candish , David Peake , Medy Tsalic , Pankaj Punia , Yuk Ting Ma
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 450)
DOI
10.1200/jco.2015.33.3_suppl.450
Abstract #
450
Poster Bd #
E17
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
A phase I fixed-dose feasibility study of MK615 and gemcitabine in patients with advanced or metastatic pancreatic cancer.
First Author: Ichiro Moriyama
Poster
2019 Gastrointestinal Cancers Symposium
Real world usage of gemcitabine and nabpaclitaxel in older adults with metastatic pancreatic cancer: A single institution experience.
First Author: Arthur Winer
Poster
2018 ASCO Quality Care Symposium
Treatment patterns, toxicity, and outcomes of elderly patients with advanced pancreatic cancer receiving first-line chemotherapy.
First Author: Robert Kudlovich
Poster
2017 Gastrointestinal Cancers Symposium
Gemcitabine and S-1 as first-line chemotherapy in patients with metastatic or advanced pancreatic cancer.
First Author: Weijia Fang